Abstract
Gaucher disease, which is caused by deficiency of glucocerebrosidase (GCD), is currently treated by enzyme replacement therapy. Plant-based systems produce glycoproteins and can be combined with targeting strategies to generate proteins with terminal mannose structures for macrophage uptake. However, the gliding step for the purification is essential since the produced protein still exists inside cells. In the case of rice-amylase 1A (RAmy1A) secretion signal peptide, GCD protein is secreted outside of cells and simplifies the purification step. Here, an established cell line was confirmed as having fundamental characteristics of growth and production. GCD from transgenic calli was examined by Western blot analysis and compared with that from Chinese hamster ovary (CHO) cells. Calli expressing high levels of GCD were used to establish suspension cell lines. Growth and production characteristics were investigated in suspension cell cultures. Production of GCD in suspension cultures was confirmed upon induction for 12–24 h. The amount of GCD in medium increased until 60–84 h and decreased thereafter. Purification of GCD was performed in three steps (ion exchange, hydrophobic interaction, and size exclusion chromatography) and verified. Purified GCD was able to hydrolyze the synthetic substrate. Thus, a rice expression system could be a suitable alternative to GCD expression in mammalian cells.
Similar content being viewed by others
References
Guggenbuhl, P., Grosbois, B., & Chales, G. (2008). Gaucher disease. Joint, Bone, Spine, 75, 116–124.
Beck, M. (2007). New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Human Genetics, 121, 1–22.
Deegan, P. B., & Cox, T. M. (2012). Imiglucerase in the treatment of Gaucher disease: a history and perspective. Drug Design Development Therapy, 6, 81–106.
Bijsterbosch, M. K., Donker, W., van de Bilt, H., van Weely, S., van Berkel, T. J., & Aerts, J. M. (1996). Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. European Journal of Biochemistry, 237, 344–349.
Doebber, T. W., Wu, M. S., Bugianesi, R. L., Ponpipom, M. M., Furbish, F. S., Barranger, J. A., Brady, R. O., & Shen, T. Y. (1982). Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. Journal of Biological Chemistry, 257, 2193–2199.
Allison, M. (2010). As Genzyme flounders, competitors and activist investors swoop in. Nature Biotechnology, 28, 3–4.
Shaaltiel, Y., Bartfeld, D., Hashmueli, S., Baum, G., Brill-Almon, E., Galili, G., Dym, O., Boldin-Adamsky, S. A., Silman, I., Sussman, J. L., Futerman, A. H., & Aviezer, D. (2007). Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnology Journal, 5, 579–590.
Fox, J. L. (2012). First plant-made biologic approved. Nature Biotechnology, 30, 472.
Grabowski, G. A., Golembo, M., & Shaaltiel, Y. (2014). Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Molecular Genetics and Metabolism, 112, 1–8.
Burrow, T. A., & Grabowski, G. A. (2011). Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigator, 1, 285–293.
Opar, A. (2011). ‘Pharmers’ hope for first plant drug harvest. Nature Reviews Drug Discovery, 10, 81–82.
Gomord, V., Chamberlain, P., Jefferis, R., & Faye, L. (2005). Biopharmaceutical production in plants: problems, solutions and opportunities. Trends in Biotechnology, 23, 559–565.
Twyman, R. M., Stoger, E., Schillberg, S., Christou, P., & Fischer, R. (2003). Molecular farming in plants: host systems and expression technology. Trends in Biotechnology, 12, 70–578.
Babajani, G., Tropak, M. B., Mahuran, D. J., & Kermode, A. R. (2012). Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant. Molecular Genetics and Metabolism, 106, 323–329.
Shin, Y. J., Chong, Y. J., Han, K. B., Yang, M. S., & Kwon, T. H. (2010). N-linked glycan analysis of glycoproteins secreted from rice cell suspension cultures under sugar starvation. Enzyme and Microbial Technology, 47, 189–193.
Taylor, M. E., & Drickamer, K. (1993). Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. Journal of Biological Chemistry, 268, 399–404.
Acknowledgments
This work was supported by a grant (No. NRF-2013M3A9B6075887) from the National Research Foundation of Korea, by a grant (No. 10051111) from the Ministry of Trade, Industry & Energy, and by Inha University.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
ESM 1
(DOCX 24 kb)
Rights and permissions
About this article
Cite this article
Nam, HJ., Kwon, JY., Choi, HY. et al. Production and Purification of Recombinant Glucocerebrosidase in Transgenic Rice Cell Suspension Cultures. Appl Biochem Biotechnol 181, 1401–1415 (2017). https://doi.org/10.1007/s12010-016-2292-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-016-2292-4